Deferiprone
Back to searchMolecule Structure
Scientific Name
Deferiprone
Description of the Drug
Deferiprone is an iron chelator used to treat patients with transfusional iron overload caused by thalassemia syndromes.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08826
http://www.drugbank.ca/drugs/DB08826
Brand Name(s)
Ferriprox
Company Owner(s)
Chiesi Usa Inc, Hikma Pharmaceuticals Usa Inc, Taro Pharmaceutical Industries Ltd
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL94474 | ||
PharmGKB | PA166118041 | ||
Human Metabolome Database | HMDB0250932 | ||
DrugBank | DB08826 | ||
PubChem: Thomson Pharma | 15120034 | ||
PubChem | 2972 | ||
Mcule | MCULE-6406005067 | ||
NMRShiftDB | 20208688 | ||
LINCS | LSM-36972 | ||
Nikkaji | J134.056E | ||
BindingDB | 50525976 | ||
EPA CompTox Dashboard | DTXSID6040666 | ||
DrugCentral | 4188 | ||
Brenda | 102002 | 223261 | 5318 |
ChemicalBook | CB0308124 | ||
Guide to Pharmacology | 7456 | ||
rxnorm | DEFERIPRONE | FERRIPROX | |
PubChem: Drugs of the Future | 12014095 | ||
ChEBI | 68554 | ||
ZINC | ZINC000000006226 |